About
Antibody Treatments for Cancer
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibody
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
5,233
By Phase
PHASE1: 2PHASE2: 3PHASE4: 1
By Status
RECRUITING: 3COMPLETED: 2UNKNOWN: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06882096Lead Sponsor
Tracing the Metabolic Flux of Orally Administered NAD+ Precursors
PHASE1Recruiting
32 participants
Started: Apr 28, 2025 · Completed: Jun 30, 2027
NCT06815991Lead Sponsor
Phase 1a Single Ascending Dose Study of MIB-725 in Healthy Adults
PHASE1Recruiting
32 participants
Started: Feb 11, 2025 · Completed: Nov 30, 2025
NCT05878119Lead Sponsor
Effects of MIB-626 With and Without A High-Intensity Multi-Dimensional Exercise Training Program
PHASE2Recruiting
120 participants
Started: Oct 25, 2023 · Completed: Jun 30, 2025
NCT05038488Lead Sponsor
Phase 2a MIB-626 vs. Placebo COVID-19
PHASE2Completed
42 participants
Started: Oct 26, 2021 · Completed: Aug 17, 2023
NCT04817111Lead Sponsor
NAD+ Precursor Supplementation in Friedreich's Ataxia
PHASE2Completed
7 participants
Started: May 17, 2021 · Completed: May 19, 2022
Locations (1)
Headquarters
Helsingborg, Sweden
Map
Loading map...